Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Columbia University: Clinical Trials & FDA Approval Profile

Columbia University (Global / Institutional) sponsors 57 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 24 active protocols (12 recruiting now), 15 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)31.6%
Median Closed Enrollment vs National (145 pts)23 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Columbia University
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)57
Active Pipeline (Recruiting Now)24 (12)
Completed vs Stopped Early15 / 18 (31.6%)
Median Closed Actual Enrollment23 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Columbia University
Hospital Research SiteLocationShared Protocols
Columbia University Irving Medical CenterNew York, NY48
Stanford Health Care and Stanford Cancer InstituteStanford, CA4
Weill Cornell MedicineNew York, NY3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Columbia University
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT03121209Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)Phase IIICOMPLETED
NCT03192215AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic StrokePhase IIITERMINATED

Explore interactive annual charts and M&A subsidiary rollups in the Columbia University Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI